Status:
COMPLETED
Study of the in Vivo Expression of MU Opioid Receptors Using PET and the Selective Tracer [C-11] Carfentanil in Normal Weight and Obese Subjects
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Nuclear Medicine
Eligibility:
MALE
18-40 years
Brief Summary
Positron emission tomography (PET) is a nuclear medicine technique that allows the measurement, in vivo in humans, with a non-invasive method, of the regional distribution of substances marked with po...
Eligibility Criteria
Inclusion
- aged between 18 and 40 years;
- structured sports activity \< 2 hours per week
Exclusion
- drug allergy;
- clinical evidence of neuropsychiatric pathologies.
Key Trial Info
Start Date :
October 22 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06180200
Start Date
October 22 2004
End Date
December 1 2007
Last Update
March 6 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.